41. THU0187 Safety of Tofacitinib, An Oral Janus Kinase Inhibitor: Integrated Data Analysis from The Global Chronic Plaque Psoriasis Clinical Trials. (15th July 2016) Authors: Langley, R.G.B.; Cohen, A.D.; Foley, P.; Griffiths, C.E.M.; Lebwohl, M.; Leonardi, C.; Winthrop, K.; Proulx, J.; Rottinghaus, S.T.; Wolk, R.; Thompson, J.R.; Tatulych, S.; Mallbris, L.; Swanson, R. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 253 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
42. Use of dose–exposure–response relationships in Phase 2 and Phase 3 guselkumab studies to optimize dose selection in psoriasis. (6th June 2019) Authors: Lebwohl, M.; Langley, R.G.; Zhu, Y.; Zhou, H.; Song, M.; Shen, Y.K.; Parnell Lafferty, K.; Reich, K. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 33:Number 11(2019) Page Start: 2082 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
43. Ustekinumab as therapy for psoriasis in a 2‐year‐old girl. (16th September 2015) Authors: Min, M.S.; Shroff, A.; Rose, S.; Lebwohl, M.; Guttman‐Yassky, E. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 30:Number 11(2016:Nov.) Page Start: e109 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
44. Utilization of the validated Psoriasis Epidemiology Screening Tool to identify signs and symptoms of psoriatic arthritis among those with psoriasis: a cross‐sectional analysis from the US‐based Corrona Psoriasis Registry. (5th March 2019) Authors: Mease, P.J.; Palmer, J.B.; Hur, P.; Strober, B.E.; Lebwohl, M.; Karki, C.; Reed, G.W.; Etzel, C.J.; Greenberg, J.D.; Helliwell, P. S. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 33:Number 5(2019) Page Start: 886 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
45. 苏金单抗持续用于治疗银屑病的疗效. (1st January 2020) Authors: Augustin, M.; Thaci, D.; Eyerich, K.; Pinter, A.; Radtke, M.; Lauffer, F.; Mrowietz, U.; Gerdes, S.; Pariser, D.; Lebwohl, M.; Sieder, C.; Melzer, N.; Reich, K. Journal: British journal of dermatology Issue: Volume 182:Number 1(2020) Page Start: e39 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
46. 苏金单抗持续用于治疗银屑病的疗效. (2nd January 2020) Authors: Augustin, M.; Thaci, D.; Eyerich, K.; Pinter, A.; Radtke, M.; Lauffer, F.; Mrowietz, U.; Gerdes, S.; Pariser, D.; Lebwohl, M.; Sieder, C.; Melzer, N.; Reich, K. Journal: British journal of dermatology Issue: Volume 182:Number 1(2020) Page Start: e39 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗